tradingkey.logo

Artivion Inc

AORT

40.550USD

-0.810-1.96%
終値 09/19, 16:00ET15分遅れの株価
1.91B時価総額
損失額直近12ヶ月PER

Artivion Inc

40.550

-0.810-1.96%
詳細情報 Artivion Inc 企業名
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
企業情報
企業コードAORT
会社名Artivion Inc
上場日Feb 12, 1993
最高経営責任者「CEO」Mr. James Patrick (Pat) Mackin
従業員数1600
証券種類Ordinary Share
決算期末Feb 12
本社所在地1655 Roberts Boulevard N W
都市KENNESAW
証券取引所NYSE Consolidated
United States of America
郵便番号30144
電話番号17704193355
ウェブサイトhttps://artivion.com/
企業コードAORT
上場日Feb 12, 1993
最高経営責任者「CEO」Mr. James Patrick (Pat) Mackin
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
48.71K
--
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
株主
更新時刻: Sun, Aug 17
更新時刻: Sun, Aug 17
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
他の
65.50%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
他の
65.50%
種類
株主統計
比率
Investment Advisor
50.47%
Investment Advisor/Hedge Fund
27.96%
Private Equity
5.92%
Individual Investor
4.71%
Hedge Fund
2.80%
Research Firm
1.28%
Pension Fund
0.94%
Bank and Trust
0.38%
Venture Capital
0.11%
他の
5.44%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
391
44.35M
103.59%
+1.98M
2025Q1
402
44.36M
103.89%
+1.66M
2024Q4
380
41.09M
97.75%
+880.04K
2024Q3
367
38.98M
93.02%
-790.24K
2024Q2
349
38.52M
92.17%
-784.32K
2024Q1
347
38.26M
91.68%
-2.02M
2023Q4
342
37.08M
90.20%
-1.57M
2023Q3
339
37.01M
90.02%
-1.95M
2023Q2
331
37.22M
87.77%
-1.77M
2023Q1
335
37.61M
88.87%
-1.51M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
5.75M
13.46%
-106.89K
-1.83%
Mar 31, 2025
Macquarie Investment Management
2.90M
6.8%
+166.78K
+6.09%
Mar 31, 2025
Perceptive Advisors LLC
2.79M
6.54%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.77M
6.49%
-22.88K
-0.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.78M
6.51%
+1.72M
+161.42%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.94M
4.54%
-50.93K
-2.56%
Mar 31, 2025
Juniper Investment Company, LLC
2.10M
4.91%
--
--
Mar 31, 2025
Wellington Management Company, LLP
1.73M
4.05%
+67.33K
+4.06%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.59%
-13.74K
-0.89%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI